Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.85% to 10402.34, DAX (0.72%) to 24603.04, CAC40 +1.01% to 8262.16, STOXX 600 +0.03% to 618.12

Feb 04 ,2026

  • Synopsis:

    • European equity markets ended mixed to mostly higher Wednesday. FTSE 100 among outperformers and hit a new record high, helped by M&A news and corporate updates. Swiss SMI and French CAC closed up 1%. DAX underperformed amid weakness in tech sector and construction/materials. OMX Copenhagen slid some 6.7% as Novo Nordisk's 2026 guidance disappointed.

    • Market looking through macro updates ahead of ECB and BoE policy updates on Thursday. Both widely expected to leave policy unchanged. London Times and CityAM shadow MPCs expect the BoE to leave key bank rate unchanged at 3.75% on Thursday. After two 5-4 split votes in November and December, CityAM panel voted 7-2 in favor of unchanged policy and London Times panel unanimous. While unemployment on the rise, there are thoughts recent inflation data and other surveys suggest upward price pressure still needs squeezing out and caution warranted. Recent business surveys and PMIs showed underlying cost pressures may still be rising, and economic activity might be holding up better than expected.

    • On the macro data front, Eurozone headline inflation eased to 1.7% y/y as expected. Big drop in energy prices an influence. Has been flagged by ECB in December meeting and incorporated in updated staff projections. Core reading weaker than forecast and services prices weaker. Final Eurozone PMI showed slowdown in activity in January, with services reading revised lower. UK services PMI revised lower, yet still highest levels in five months. Think tank NIESR estimates that Chancellor Reeves has already run out of fiscal headroom despite building bigger buffer of £20B via £26B in tax rises.

    • Busy session for European earnings, with banks, pharmas in focus. Banco Santander (SAN.SM) (3.5%) reported Q4 attributable net income €3.76B vs FactSet €3.45B and agreed to acquire Webster Bank (WBS) for $12.2B in cash and shares. Shares downgraded to equal-weight from overweight at Morgan Stanley and to neutral from buy at Alantra Equities. Credit Agricole (ACA.FP) reported Q4 net income €1.03B vs consensus €960.3M, raised dividend +3% y/y. DNB Bank (DNB.NO) +2.3% reported Q4 net income NOK11.2B vs consensus NOK10.0B, raised dividend ~ +7.5% y/y, initiated share buy-back program. Svenska Handelsbanken (SHB.A.SS) reported Q4 EPS SEK3.01 vs FactSet SEK2.73. UBS (UBSG.SW) shares lower on back of its earnings; In pharma, Novartis (NOVN.SW) reported mixed Q4; softer FY26 guidance implies cuts to consensus. GSK (GSK.LN) reported in-line to better than expected Q4/FY result; consensus already at top end of FY26 guidance. GSK also reaffirmed 2031 sales outlook of more than £40B. Novo Nordisk (NOVO.B.DC) strong Q4 earnings overshadowed by cautious 2026 guidance pointing to declines in sales and EBIT; shares dived. In insurance space, Zurich Insurance Group (ZURN.SW) and Beazley (BEZ.LN) have reached agreement in principle: Beazley shareholders to receive a total value of up to 1,335p per Beazley share. Infineon (IFX.GR) reported results and also confirmed acquisition of the non-optical analog/mixed-signal sensor portfolio from ams OSRAM Group (AMS.SW) for €570M. Henkel (HEN3.GR) agreed to acquire Stahl Parent B.V. for a purchase price of €2.1B

    • Elsewhere, focus remained on sharp selloff in European software, data and advertising names amid sharp re-pricing of business-model risk following Anthropic's Claude legal plug-in news yesterday, which crystallized fears over AI disruption.

    • European building materials stocks such as HEI.GR and HOLN.SW under pressure while chemicals advanced, following Handelsblatt reported EU Commission plans to weaken EU Emissions Trading System (ETS) by increasing available emission certificates and delaying auction deadlines. Commission did not confirm report, stating it would present ETS review proposals in July (Carbon-Pulse). Goldman Sachs warned lower CO2 prices from increased allowances could reduce marginal costs for high-emitting producers, spurring near-term price competition and eroding profits. Long-term, greater allowances could diminish competitive advantages for decarbonization leaders and weaken carbon capture investment cases. Autos & Parts benefited from M&A and partnership chatter, including Ford-Geely tech-sharing discussions and Tesla's (TSLA) 9% China shipment gain.

    • Looking ahead to tomorrow, apart from the BoE and ECB announcements, focus on another heavy earnings session with rcelorMittal (MT.NA), Assa Abloy (ASSA.B.SS), BNP Paribas (BNP.FP), BBVA (BBVA.SM), Shell (SHEL.LN) and BMW (BMW.GR) among the many names on the agenda. Macro data releases out tomorrow include Germany Dec factory orders, industrial production, Jan construction PMI, France Dec industrial production, Italy Dec retail sales, Eurozone Dec retail sales, UK Jan construction PMI.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Chemicals +4.76%, Autos & Parts +3.61%, Telecom +3.57%, Food & Beverage +2.74%, Travel & Leisure +2.24%, Retail +2.08%, Persnl & HHold Goods +1.69%, Insurance +1.58%, Real Estate +1.00%, Utilities +0.93%, Oil & Gas +0.60%

      • Underperformers:

        • Technology (2.52%), Financial Svcs (1.31%), Basic Resources (1.28%), Ind Goods & Svcs (1.23%), Banks (0.87%), Media (0.71%), Construct & Mtls (0.66%), Health Care (0.34%)

    • Macro:

      • EU lawmakers decide to resume work on enacting U.S. trade deal -- Reuters

      • Eurozone inflation drops well below target ahead of ECB rate decision -- ING Think

      • Italy budget watchdog UPB raises 2026 GDP growth to 0.7%, lowers 2027 -- Reuters

      • Italy, France and Germany to lead EU critical materials stockpiling plan, sources say -- Reuters

      • European Council agrees position on legal framework to provide €90B in financial support to Ukraine -- link

      • Polish Central Bank Holds Rates Again as Economy Accelerates -- Bloomberg

      • EU is weakening its most important climate protection instrument and extending free certificate -- Handelsblatt

    • Company news:

      • Notable Gainers

        • +60.4% GEMD.LN (Gem Diamonds £0.05, +0.02) -- Q4 trading update

        • +24.2% SOI.FP (SOITEC €30.04, +5.94) -- Q3 revenue

        • +15.1% ALIF.B.SS (AddLife SEK156.80, +20.40) -- Q4 earnings

        • +13.3% CLN.SW (Clariant CHF8.34, +0.96) -- sale of 14.6% stake in Stahl Parent B.V. to Henkel

        • +10.6% DCC.LN (DCC £50.85, +4.90) -- Q3 trading statement

        • +10.5% ENT.LN (Entain £0.00, +0.62) -- reports BetMGM FY25 Business Update; expects FY26 Net Revenue between $3.1 - $3.2B and adj EBITDA between $300 - $350M

        • +9.9% AUS.GR (AT & S Austria Technologie & Systemtechnik €50.20, +4.50)

        • +9.9% LOOMIS.SS (Loomis SEK407.00, +36.60) -- Q4 earnings

        • +9.8% SVED.B.SS (Svedbergs Group SEK72.80, +6.50) -- Q4 earnings

        • +9.0% MF.FP (Wendel €87.70, +7.30) -- acquires Stahl Parent B.V. for €2.1B

        • +7.6% STERV.FH (Stora Enso €10.59, +0.75) -- Q4 earnings

        • +7.6% GSK.LN (GSK Plc £20.63, +1.48) -- Q4 earnings

        • +7.4% WEW.GR (Westwing Group €14.90, +1.05) -- initiated buy at Berenberg

        • +7.3% BEZ.LN (Beazley £12.57, +0.85) -- agrees to Zurich Insurance Group offer of 1,335p/sh

        • +7.0% CICN.SW (Cicor Technologies CHF132.50, +8.50) -- initiated buy at UBS

        • +6.7% ROCK.B.DC (Rockwool DKK0.00, +14.40) -- Q4 earnings

        • +6.3% UPM.FH (UPM-Kymmene €25.41, +1.49) -- Q4 earnings

        • +5.6% AMBU.B.DC (Ambu DKK87.75, +4.65) -- Q1 earnings

        • +5.2% BAS.GR (BASF SE €49.39, +2.46) -- sale of 16.1% stake in Stahl Parent B.V. to Henkel

        • +5.1% OMV.AV (OMV €52.15, +2.55) -- Q4 earnings

        • +4.7% AMS.SW (ams-OSRAM CHF8.44, +0.37) -- sale of non-optical analog/mixed-signal sensor business to Infineon for €570M in cash

        • +4.1% FORTUM.FH (Fortum €20.14, +0.78) -- Inderes upgrade

        • +4.0% LRE.LN (Lancashire Holdings £6.45, +0.25)

        • +3.7% BKG.LN (Berkeley Group Holdings £43.74, +1.56) -- JPMorgan upgrade

        • +3.6% SCR.FP (SCOR SE €29.02, +1.00) -- Jan. 2026 P&C reinsurance renewals; management changes

        • +3.6% DSV.DC (DSV A/S DKK1,840.00, +64.50) -- Q4 earnings

        • +3.3% DNB.NO (DNB Bank NOK293.00, +9.40) -- Q4 earnings; share buy-back programme of up to 0.5% of its share capital

        • +3.1% PEAB.B.SS (Peab SEK93.70, +2.75) -- Q4 earnings

        • +2.4% SHB.A.SS (Svenska Handelsbanken SEK149.00, +3.50) -- Q4 earnings

        • +2.3% CLA.B.SS (Cloetta SEK45.90, +1.02) -- Q4 earnings

        • +1.6% OXB.LN (OXB £8.37, +0.13) -- new multi-year commercial supply agreement with Bristol Myers Squibb

        • +0.3% RILBA.DC (Ringkjøbing Landbobank DKK1,643.00, +5.00) -- new distribution policy

      • Notable Decliners

        • -19.0% PCELL.SS (PowerCell Sweden SEK20.92, -5.04) -- Q4 earnings

        • -17.2% NOVO.B.DC (Novo Nordisk DKK307.45, -63.15) -- Q4 earnings; initiates first DKK3.8B tranche of its DKK15B new buyback

        • -14.5% TPE.GR (PVA TePla €21.54, -3.64) -- prelim. FY earnings

        • -13.5% TOM2.NA (TomTom €5.36, -0.82) -- Q4 earnings

        • -12.9% DNORD.DC (D/S Norden DKK256.00, -36.80) -- FY earnings

        • -9.8% HEI.GR (Heidelberg Materials €214.80, -23.30) -- EU plans to weaken ETS by extending free certificates - Handelsblatt

        • -8.5% TKA.GR (ThyssenKrupp €11.22, -1.01)

        • -8.5% A1OS.GR (All for One Group €39.40, -3.60) -- Q1 earnings

        • -8.5% ATYM.LN (Atalaya Mining £9.48, -0.87) -- holder Urion Holdings (Malta) Limited (Trafigura) places ~13M at 945p/each

        • -8.4% HUSQ.B.SS (Husqvarna SEK42.04, -3.91) -- Q4 earnings; CFO steps down

        • -7.9% LHN.SW (Holcim CHF76.68, -6.50) -- EU plans to weaken ETS by extending free certificates - Handelsblatt

        • -6.9% BIOA.B.SS (BioArctic SEK318.40, -22.80)

        • -6.7% QLINEA.SS (Q-linea SEK24.39, -1.73) -- Q4 earnings

        • -6.4% SIE.GR (Siemens AG €242.75, -16.70)

        • -6.3% NETC.DC (Netcompany Group DKK332.20, -22.20) -- SEB upgrade

        • -6.3% UBSG.SW (UBS Group CHF35.17, -2.32) -- Q4 earnings

        • -6.3% WRT1V.FH (Wartsila €33.48, -2.21) -- Q4 earnings; further expands production capacity in Finland by 35%

        • -6.1% BRG.NO (Borregaard NOK183.20, -11.80) -- Q4 earnings

        • -5.7% YOU.LN (YouGov £2.10, -0.13) -- H1 trading update

        • -4.8% MELE.BB (Melexis €57.50, -2.90) -- FY earnings

        • -4.5% PRX.NA (Prosus €45.76, -2.14) -- three-year agreement with Amazon Web Services (AWS) to scale AI applications

        • -4.2% DIM.FP (Sartorius Stedim Biotech €184.45, -8.15)

        • -3.7% ODF.NO (Odfjell NOK131.40, -5.00) -- Norne Securities downgrade

        • -3.6% KNOS.LN (Kainos Group £8.00, -0.31)

        • -3.5% SAN.SM (Banco Santander €10.81, -0.39) -- Q4 earnings; acquires Webster Bank for $12.2B in 65% cash and 35% stock; Morgan Stanley downgrade; Alantra Equities downgrade

        • -3.3% BONAV.B.SS (Bonava SEK13.00, -0.44) -- Q4 earnings

        • -3.2% VITR.SS (Vitrolife SEK89.50, -2.90)

        • -3.2% BARC.LN (Barclays £0.00, -0.16) -- Barclays and NatWest to be involved this week in the bidding process for Evelyn Partners at more than £2B for the wealth management group - Sky

        • -2.9% WOSG.LN (Watches of Switzerland Group £4.94, -0.15) -- Q3 trading update

        • -2.8% ACA.FP (Credit Agricole €18.18, -0.52) -- Q4 earnings

        • -2.5% WPP.LN (WPP Group £2.58, -0.07)

        • -2.2% SF.SS (Stillfront Group SEK4.60, -0.11) -- final FY earnings

        • -2.1% DEMANT.DC (Demant DKK194.30, -4.10) -- ABG Sundal Collier downgrade

        • -2.0% IFX.GR (Infineon Technologies €39.53, -0.84) -- Q1 earnings

        • -2.0% HBR.LN (Harbour Energy £2.26, -0.05) -- Goldman Sachs downgrade

        • -1.9% PUB.FP (Publicis Groupe €74.94, -1.46) -- Barclays downgrade

        • -1.6% LSEG.LN (London Stock Exchange Group £71.10, -1.12)

        • -1.4% ENOG.LN (Energean £8.59, -0.12) -- Jefferies downgrade

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: ArcelorMittal (MT.NA)

        • Germany: Siemens Healthineers (SHL.GR), Aurubis (NDA.GR), Heidelberger Druckmaschinen (HDD.GR), Novem Group (NVM.GR), Bastei Lübbe (BST.GR), Dynavox Group (DYVOX.GR)

        • Switzerland: Valiant Holding (VATN.SW), Swiss Prime Site (SPSN.SW), Luzerner Kantonalbank (LUKN.SW)

        • France: BNP Paribas (BNP.FP), VINCI (DG.FP), X-FAB Silicon Foundries (XFAB.FP)

        • Denmark: Maersk (MAERSK.B.DC), Danske Bank (DANSKE.DC), Vestas Wind Systems (VWS.DC), Genmab (GMAB.DC), Pandora (PNDORA.DC), GN Store Nord (GN.DC), Solar (SOLAR.B.DC), NNIT (NNIT.DC), Gabriel Holding (GABR.DC)

        • Sweden: Assa Abloy (ASSA.B.SS), Saab (SAAB.B.SS), Swedish Orphan Biovitrum (SOBI.SS), Evolution (EVO.SS), Volvo Car (VOLCAR.B.SS), Addtech (ADDT.B.SS), AarhusKarlshamn (AAK.SS), Mycronic (MYCR.SS), Fabege (FABG.SS), Wallenstam (WALL.B.SS), Pandox (PNDX.B.SS), NCC (NCC.B.SS), Röko (ROKO.B.SS), Bufab (BUFAB.SS), AFRY (AFRY.SS), Nolato (NOLA.B.SS), Norion Bank (NORION.SS), Attendo (ATT.SS), Betsson (BETSB.SS), Modern Times Group MTG (MTG.B.SS), Bilia (BILI.A.SS), New Wave Group (NEWA.B.SS), Troax Group (TROAX.SS), Scandi Standard (SCST.SS), MilDef Group (MILDEF.SS), Fenix Outdoor International (FOI.B.SS), Eastnine (EAST.SS), Hexatronic Group (HTRO.SS), XANO Industri (XANO.B.SS), Hansa Biopharma (HNSA.SS), Rejlers (REJL.B.SS), CellaVision (CEVI.SS), Studsvik (SVIK.SS), Nobia (NOBI.SS), Rugvista Group (RUG.SS), Orexo (ORX.SS), Pricer (PRIC.B.SS), Fractal Gaming Group (FRACTL.SS), I-Tech (ITECH.SS), Bactiguard Holding (BACTI.B.SS), Ascelia Pharma (ACE.SS), Fingerprint Cards (FING.B.SS)

        • Finland: Sampo (SAMPO.FH), Neste (NESTE.FH), Konecranes (KCR.FH), Kesko (KESKOB.FH), Alma Media (ALMA.FH), Fiskars (FSKRS.FH), Aktia Bank (AKTIA.FH), Metsa Board (METSB.FH), F-Secure (FSECURE.FH), Digia (DIGIA.FH), Detection Technology (DETEC.FH)

        • Norway: Nordic Semiconductor (NOD.NO), DNO (DNO.NO), BW Energy (BWE.NO), Norske Skog (NSKOG.NO)

        • Southern Europe: Banco Bilbao Vizcaya Argentaria (BBVA.SM), Logista Integral (LOG.SM), Banco BPM (BAMI.IM), FinecoBank (FBK.IM), Credito Emiliano (CE.IM)

        • UK: Shell (SHEL.LN)

        • Other: Icelandair Group (ICEAIR.IR)

      • Trading Update:

        • DACHs: Bayerische Motoren Werke (BMW.GR), Renk Group (R3NK.GR)

        • France: Equasens Group (EQS.FP), Guerbet (GBT.FP)

        • UK: Anglo American (AAL.LN), Compass Group (CPG.LN), Vodafone Group (VOD.LN)

      • Traffic: Norwegian Air Shuttle (NAS.NO), Finnair (FIA1S.FH)

      • CMD/Events: Hannover Re (HNR1.GR), Sligro Food Group (SLIGR.NA), Cereno Scientific (CRNO.B.SS)

  • Data:

    • Economics:

      • Jan Services PMI

        • UK 54.0 vs preliminary 54.3

        • Eurozone 51.6 vs consensus 51.9 and prior 52.4

        • Germany 52.4 vs consensus 53.3 and prior 52.7

        • France 48.4 vs consensus 47.9 and prior 50.1

        • Italy 52.9 vs cons 51.4 and prior 51.5

        • Sweden 54.3 vs cons 55.5 and prior revised 56.3 from 56.7

        • Spain 53.5 vs cons 56.6 and prior 57.1

      • Jan Prelim CPI

        • Netherlands +2.4% y/y vs cons +2.9% and prior +2.8%

        • Finland +1.0% y/y vs cons +1.6% and prior +1.7%

        • Austria +2.0% y/y vs cons +3.1% and prior +3.8%

    • Markets:

      • WTI Crude (Mar 26): +$0.09 or +0.14% to $63.30

      • €-$ (0.0023) or (0.19%) to 1.1796

      • £-$ (0.0050) or (0.37%) to 1.3648

      • €-£ +0.0016 to 0.8645

      • S&P 500 (0.56%)

      • Performance year-to-date

        • FTSE 100: +4.74%

        • DAX: +0.46%

        • CAC: +1.38%

        • MIB: +3.76%

        • Stoxx 600: +4.38%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE